TABLE 5.
Deficiency stock | Left end | Right end | Viability with KE1-1 and KE1-2 |
---|---|---|---|
BL-2604 | 60C6 | 60D9–10 | Lethal |
Df(2R)Exel6278 | 60C7 | 60D4 | Viable |
Df(2R)Exel6278 | 60C7 | 60D4 | Viable |
Df(2R)Exel9043 | 60C7 | 60C7 | Viable |
Df(2R)Exel7185 | 60C8 | 60D3 | Viable |
Df(2R)Exel7186a | 60D10 | 60E1 | Viable |
Df(2R)Exel8091a | 60D4 | 60D14 | Lethal |
Deficiency name or stock number tested is given in column 1. The left- and right-hand cytogenetic locations are given in columns 2 and 3, and the lethality or viability when the deficiency was scored with KE1-1 and KE1-2 is given in column 4.
Df was not permanently stocked.